Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This study was initially designed to test the efficacy of Venlafaxine HCl in reducing
incidence of the onset of major depression after a new spinal cord injury (SCI). After
several protocol modifications, the purpose of the study is to test the effectiveness of a
sub-therapeutic dose of Venlafaxine HCl to reduce mild to moderate symptoms in persons with
SCI.